Publications by authors named "Sheldon Freedman"

Claim this Profile
1
12-Month Outcomes from a Randomized, Sham Controlled Trial Evaluating a Novel Prostatic Urethral Stent for the Treatment of Benign Prostatic Hyperplasia.
Steven A Kaplan, Sijo J Parekattil, Ning Z Wu, Brian Mazzarella, Michael Trotter, Sheldon Freedman

J Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preservation of sexual function with Optilume-a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Olivia Copelan, Jared Moss, Sheldon Freedman, Karl Coutinho, Dean Elterman

J Sex Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year long-term follow-up of treatment with the Optilume BPH catheter system in a randomized controlled trial for benign prostatic hyperplasia (The PINNACLE Study).
Steven A Kaplan, Jared L Moss, Sheldon J Freedman

Prostate Cancer Prostatic Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Steven A Kaplan, Jared Moss, Sheldon Freedman, Karl Coutinho, Ning Wu

J Urol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Steven A Kaplan, Jared Moss, Sheldon Freedman, Karl Coutinho, Ning Wu

J Urol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results.
Neal Shore, Steven A Kaplan, Ronald Tutrone, Richard Levin, James Bailen, Sheldon Freedman

World J Urol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Video-Based Patient Education Program to Reduce Penile Prosthetic Surgery Cancellations.
Eric Ballon-Landa, Raul Clavijo, Martin Gross, Ashley Tapscott, Ranjith Ramasamy, Sheldon Freedman

Am J Mens Health· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study.
Daniel Rukstalis, Douglas Grier, Sean P Stroup, Ronald Tutrone, Euclid deSouza, Sheldon Freedman

Prostate Cancer Prostatic Dis· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Evidence of Prostatic Urethral Lift Confirms Pivotal Clinical Study Results: 2-Year Outcomes of a Retrospective Multicenter Study.
Gregg Eure, Steven Gange, Peter Walter, Ansar Khan, Charles Chabert, Sheldon Freedman

J Endourol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fexapotide triflutate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement.
Neal Shore, Ronald Tutrone, Mitchell Efros, Mohamed Bidair, Barton Wachs, Sheldon Freedman

World J Urol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study.
Claus G Roehrborn, Jack Barkin, Steven N Gange, Neal D Shore, Jonathan L Giddens, Sheldon J Freedman

Can J Urol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three year results of the prostatic urethral L.I.F.T. study.
Claus G Roehrborn, Daniel B Rukstalis, Jack Barkin, Steven N Gange, Neal D Shore, Sheldon J Freedman

Can J Urol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of the Prostatic Urethral Lift: 2-Year Results of the L.I.F.T. Study.
Claus G Roehrborn, Steven N Gange, Neal D Shore, Jonathan L Giddens, Damien M Bolton, Sheldon J Freedman

Urol Pract· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective multi-center study elucidating patient experience after prostatic urethral lift.
Neal Shore, Sheldon Freedman, Steven Gange, William Moseley, Sean Heron

Can J Urol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.
Claus G Roehrborn, Steven N Gange, Neal D Shore, Jonathan L Giddens, Damien M Bolton, Sheldon J Freedman

J Urol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: a prospective study of 1,962 cases.
E David Crawford, Kyle O Rove, Edouard J Trabulsi, Junqi Qian, Krystyna P Drewnowska, Sheldon J Freedman

J Urol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective multicenter trial assessing type I, polypropylene mesh placed via transobturator route for the treatment of anterior vaginal prolapse with 2-year follow-up.
Robert D Moore, Roger D Beyer, Karny Jacoby, Sheldon J Freedman, Kurt A McCammon

Int Urogynecol J· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of dutasteride in the four-year treatment of men with benign prostatic hyperplasia.
Claus G Roehrborn, Leonard S Marks, Tom Fenter, Sheldon Freedman, John Tuttle

Urology· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sacral neuromodulation as an effective treatment for refractory pelvic floor dysfunction.
Sherif Aboseif, Kirk Tamaddon, Stuart Chalfin, Sheldon Freedman, John Kaptein

Urology· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis